Sleep Aids

Global Sleep Aids Market to Reach US$110.8 Billion by 2030

The global market for Sleep Aids estimated at US$75.4 Billion in the year 2024, is expected to reach US$110.8 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Medications, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$56.6 Billion by the end of the analysis period. Growth in the Sleep Apnea Devices segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$20.5 Billion While China is Forecast to Grow at 10.7% CAGR

The Sleep Aids market in the U.S. is estimated at US$20.5 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$23.2 Billion by the year 2030 trailing a CAGR of 10.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global "Sleep Aids" Market – Key Trends & Drivers Summarized

Why Is The Demand For Sleep Aids Skyrocketing In Modern Societies?
Sleep aids have become essential tools in combating the global epidemic of sleep disorders—ranging from insomnia, sleep apnea, and narcolepsy to circadian rhythm disruptions and restless leg syndrome. Factors such as rising stress levels, screen time, erratic work hours, and poor sleep hygiene have significantly increased the incidence of both acute and chronic sleep issues worldwide. According to the World Health Organization, nearly one-third of the global population suffers from some form of sleep disturbance, making sleep health a critical component of public wellness. Sleep aids—encompassing pharmaceuticals, natural supplements, sleep-inducing devices, and behavioral therapy tools—offer varied options to restore and regulate healthy sleep patterns. Modern consumers are not only looking for relief from insomnia but also seeking performance optimization, better mental health, and holistic well-being—all of which are intricately tied to sleep quality. As sleep becomes central to the wellness narrative, the role of sleep aids has evolved from reactive treatment to proactive lifestyle management. This shift is fueling massive market expansion across age groups, income segments, and global geographies. From jet-lagged executives to aging adults and anxious teens, sleep aids are now seen as practical, accessible solutions to a universal human need.

How Are Innovations In Sleep Technology And Supplements Redefining Restorative Sleep?
The sleep aids market is being reshaped by a wave of technological and biochemical innovations aimed at offering non-invasive, drug-free, and personalized approaches to better sleep. Smart sleep devices—such as wearable trackers, smart mattresses, and brainwave headbands—use biometric sensors and AI algorithms to monitor and optimize sleep cycles in real time. White noise machines, circadian lighting systems, and guided sleep apps are helping to create ambient environments that support natural melatonin production and sleep onset. On the pharmaceutical front, newer-generation hypnotics like orexin receptor antagonists (e.g., suvorexant) provide targeted sleep regulation with fewer dependency risks than older sedatives. Meanwhile, the nutraceutical segment is booming with increased demand for melatonin, magnesium, valerian root, L-theanine, and CBD-based sleep supplements, driven by their over-the-counter availability and lower side-effect profiles. Functional beverages and sleep gummies are emerging as consumer-friendly delivery formats, especially among millennials and Gen Z. Companies are also investing in sleep coaching apps and telehealth platforms that offer cognitive behavioral therapy for insomnia (CBT-I), now recognized as a gold-standard treatment. These innovations reflect a growing preference for holistic, data-driven, and side-effect-free solutions—shifting the sleep aids market from symptom management to comprehensive sleep optimization.

Where Are Sleep Aids Creating Value Across Demographics, Health Sectors, And Global Regions?
Sleep aids are generating measurable value across a wide spectrum of use cases and populations. In the elderly, where sleep fragmentation is common due to chronic conditions and medication interactions, sleep aids are crucial for maintaining cognitive function and emotional well-being. In working adults, particularly shift workers and frequent travelers, sleep solutions are vital for reducing fatigue, enhancing productivity, and supporting mental health. Adolescents and college students, increasingly affected by anxiety, tech overexposure, and academic stress, are turning to sleep apps, blue-light-blocking solutions, and natural remedies. In clinical settings, sleep aids play a critical role in treating comorbid sleep disorders in patients with depression, PTSD, ADHD, and neurodegenerative diseases like Alzheimer’s. In the wellness industry, sleep solutions are being bundled into personalized health packages, including fitness trackers, mental wellness subscriptions, and spa treatments. Geographically, North America dominates the market due to high awareness, insurance coverage, and advanced healthcare infrastructure. However, Asia-Pacific is emerging as a high-growth region due to rising disposable income, urbanization, and increased diagnoses of sleep apnea and insomnia. Sleep labs, hospital sleep centers, and retail pharmacies across Europe and the Middle East are also expanding sleep aid offerings. This widespread adoption across sectors—from clinical therapy to consumer wellness—underscores sleep aids’ versatility and relevance in today’s health-focused culture.

The Growth In The Sleep Aids Market Is Driven By Several Factors That Reflect Shifting Lifestyles, Medical Needs, Consumer Preferences, And Technological Access
One of the primary growth drivers is the increasing prevalence of sleep disorders, driven by modern lifestyle stressors, mental health conditions, and physical comorbidities like obesity and diabetes. Growing awareness of the long-term impact of poor sleep on immunity, heart health, and mental performance is also pushing individuals toward early intervention. Demand for non-prescription, natural, and drug-free alternatives is fueling innovation in the nutraceutical and wellness segments, while regulatory support for CBD-based sleep solutions is opening new markets. The rise in wearable technology and health-focused mobile apps has made sleep tracking and optimization more accessible, especially among tech-savvy demographics. Telemedicine platforms offering CBT-I are expanding access to evidence-based therapy in rural and underserved regions. In the workplace, rising investments in employee well-being are spurring corporate adoption of sleep education and support tools. Retail availability through pharmacies, e-commerce, and wellness platforms is expanding product reach, while aggressive marketing and influencer-led awareness campaigns are amplifying consumer engagement. Additionally, rising healthcare costs and the shift toward preventive health are prompting consumers to invest more in sleep management as a foundational wellness practice. These interconnected drivers—medical, technological, behavioral, and economic—are collectively powering the rapid and multidimensional growth of the global sleep aids market.

SCOPE OF STUDY:

The report analyzes the Sleep Aids market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Medications, Sleep Apnea Devices, Mattresses & Pillows, Other Product Types); Sleep Disorder (Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors, Other Sleep Disorders)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• AstraZeneca Plc
• BMC Medical Co., Ltd.
• Cadwell Industries, Inc.
• Compumedics Limited
• Drive DeVilbiss Healthcare Inc.
• Eisai Co., Ltd.
• Fisher & Paykel Healthcare Ltd.
• GlaxoSmithKline Plc
• Idorsia Pharmaceuticals Ltd.
• Itamar Medical Ltd.
• Koninklijke Philips N.V.
• LG Electronics Inc.
• Merck & Co., Inc.
• Natus Medical Incorporated
• Novartis AG
• Pfizer Inc.
• ResMed Inc.
• Sanofi S.A.
• SleepMed Inc.
• Teva Pharmaceutical Industries Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.